A significant clinical finding has emerged from recent research examining L-arginine’s effects on cerebral circulation: adults over 65 receiving supplementation demonstrated a 15-20% improvement in cerebral blood flow, with measurable cognitive benefits observed throughout the trial period. This result represents a substantial shift in how researchers view the amino acid’s therapeutic potential.
These improvements occur independently of the supplement’s established cardiovascular benefits, suggesting distinct neurological mechanisms at work. The enhanced brain blood flow correlates with improved cognitive performance metrics, indicating practical clinical relevance beyond laboratory observations.
This data challenges the traditional narrative that L-arginine’s primary value lies solely in vascular function. For clinicians and researchers focused on cognitive aging and cerebrovascular health, these findings warrant consideration as emerging evidence supporting broader applications of amino acid supplementation in neuroprotection strategies.
Was this article helpful?
